Active Pharmaceutical Ingredient (API)
Teplizumab
Type 1 Diabetes Immunotherapy
A CD3-directed antibody that delays the onset of Stage 3 Type 1 diabetes in at-risk individuals by modifying T-cell response.
Technical Profile
- Reference Code
- IMM1007
- CAS Number
- 11096-26-7
- Molecular Weight
- 145,000.00 g/mol
- Chemical Class
- N/A
- Molecular Formula
- Variable
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Teplizumab as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| No verified brands found for this salt. | ||||